Fact CheckerSign in

NCT05649670Recruiting

Acute Stroke: Prehospital Versus In-HospitAL Initiation of Recanalization Therapy- ASPHALT

Prehospital Initiation of Reperfusion Therapy for Acute Ischemic Stroke: Randomized Medico-economic Evaluation of a Mobile Stroke Unit.

Source: ClinicalTrials.gov · Last updated 1 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

ASPHALT is an academic-driven open-label randomized controlled trial of Mobile Stroke Unit (MSU) deployment versus standard care in France, with blinded assessment of efficacy endpoints. 450 patients with confirmed acute ischemic stroke will be recruited over a 3-year period, with 3-month follow-up.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
450 (estimated)
First submitted
2 Dec 2022
Start date
16 Oct 2023
Primary completion date
16 Oct 2026
Lead sponsor
Centre Hospitalier St Anne
Diseases
Stroke
NCT number
NCT05649670

What you commit to

  • Study type: Interventional
  • Planned participants: 450
  • From 16 Oct 2023 to the primary completion date, 16 Oct 2026
  • 11 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Unknown or uncertain onset time (e.g. wake-up stroke)
  • Medical history of epilepsy
  • Recent epileptic seizure (\<12 hrs)

Other

  • Patient confined to be more than 50% of waking hours
  • Suspicion of pregnancy
  • Parturient or breastfeeding woman
  • Patient already participating in another interventional study, which could influence the mRS at 3 months.
  • Patient under guardianship or curatorship
  • Patient not affiliated to French Social Security

Who the study is looking for

  • Emergency call to one of the two following emergency medical service (EMS) dispatch centers : SAMU (Service d'Aide Médicale Urgente) or BSPP (Brigade des Sapeurs Pompiers de Paris), between 08:00 and 18:00, 5 days a week (Monday to Friday).
  • Suspected acute stroke according to a dispatcher stroke identification algorithm, adapted from the ROSIER scale
  • Symptom onset-to-randomization time ≤ 6h
  • Patient located within the predefined catchment area of the MSU
  • MSU available at the time of the EMS call
  • Informed consent (as approved by the ethics committee, informed consent will be obtained after randomization: at the arrival of the MSU (intervention group), or at hospital arrival (control group))

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (11)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
AP-HP - hôpital Raymond Poincaré
Coordinator of this site? Confirm its status
GarchesFranceRecruiting
AP-HP Hopital Bicetre
Coordinator of this site? Confirm its status
Le Kremlin-BicêtreFranceRecruiting
Fondation Ophtalmologique Rothschild
Coordinator of this site? Confirm its status
ParisFranceRecruiting
AP-HP, Hôpital de la Pitié Salpêtrière
Coordinator of this site? Confirm its status
ParisFranceRecruiting
BSPP, Brigade des Sapeurs-Pompiers de Paris
Coordinator of this site? Confirm its status
ParisFranceRecruiting
AP-HP Hôpital Bichat Claude-Bernard
Coordinator of this site? Confirm its status
ParisFranceRecruiting
AP-HP Hopital Lariboisiere
Coordinator of this site? Confirm its status
ParisFranceRecruiting
GHU Paris Psychiatrie & Neurosciences
Coordinator of this site? Confirm its status
ParisFranceRecruiting
Hopital Saint Joseph
Coordinator of this site? Confirm its status
ParisFranceNot yet recruiting
SAMU 75 de Paris
Coordinator of this site? Confirm its status
ParisFranceRecruiting
Hopital Foch
Coordinator of this site? Confirm its status
SuresnesFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.